Literature DB >> 15936907

Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers.

A Beletsi1, Z Panagi, K Avgoustakis.   

Abstract

The basic characteristics and the biodistribution properties of nanoparticles prepared from mixtures of poly(lactide-co-glycolide) (PLGA) with poly(lactide-co-glycolide)-poly(ethylene glycol) (PLGA-PEG) copolymers were investigated. A PLGA(45)-PEG(5) copolymer of relatively low PEG content and a PLGA(5)-PEG(5) copolymer of relatively high PEG content were included in the study. Increasing the PLGA-PEG content of the PLGA/PLGA-PEG mixture, or when PLGA(45)-PEG(5) was replaced by PLGA(5)-PEG(5), a decrease in the size of the nanoparticles and an increase in the rate of PEG loss from the nanoparticles were observed. The blood residence of the PLGA/PLGA(45)-PEG(5) nanoparticles increased as their PLGA-PEG content was increased, reaching maximum blood longevity at 100% PLGA(45)-PEG(5). On the contrary, the blood residence of PLGA/PLGA(5)-PEG(5) nanoparticles exhibited a plateau maximum in the range of 80-100% PLGA(5)-PEG(5). At PLGA-PEG proportions lower than 80%, the PLGA/PLGA(45)-PEG(5) nanoparticles exhibited lower blood residence than the PLGA/PLGA(5)-PEG(5) nanoparticles, whereas at PLGA-PEG proportions higher than 80%, the PLGA/PLGA(45)-PEG(5) nanoparticles exhibited higher blood residence than the PLGA/PLGA(5)-PEG(5) nanoparticles. These findings indicate that apart from the surface PEG content, the biodistribution properties of the PLGA/PLGA-PEG nanoparticles are also influenced by the size of the nanoparticles and the rate of PEG loss from the nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936907     DOI: 10.1016/j.ijpharm.2005.03.024

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  28 in total

1.  Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel.

Authors:  Danial Barati; Seyed Ramin Pajoum Shariati; Seyedsina Moeinzadeh; Juan M Melero-Martin; Ali Khademhosseini; Esmaiel Jabbari
Journal:  J Control Release       Date:  2015-12-22       Impact factor: 9.776

2.  Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates.

Authors:  Jason Park; Thomas Mattessich; Steven M Jay; Atu Agawu; W Mark Saltzman; Tarek M Fahmy
Journal:  J Control Release       Date:  2011-06-24       Impact factor: 9.776

Review 3.  Exploiting the tumor phenotype using biodegradable submicron carriers of chemotherapeutic drugs.

Authors:  Sean M Geary; Aliasger K Salem
Journal:  Crit Rev Oncog       Date:  2014

4.  Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics.

Authors:  Sean Marrache; Shanta Dhar
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-18       Impact factor: 11.205

5.  Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.

Authors:  Imran A Babar; Christopher J Cheng; Carmen J Booth; Xianping Liang; Joanne B Weidhaas; W Mark Saltzman; Frank J Slack
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-08       Impact factor: 11.205

6.  Heterogeneity in nanoparticles influences biodistribution and targeting.

Authors:  Isaac M Adjei; Chiranjeevi Peetla; Vinod Labhasetwar
Journal:  Nanomedicine (Lond)       Date:  2013-06-26       Impact factor: 5.307

Review 7.  Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Authors:  Frank Alexis; Eric Pridgen; Linda K Molnar; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2008-08-04       Impact factor: 4.939

8.  Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.

Authors:  Katayoun Derakhshandeh; Marzieh Soheili; Simin Dadashzadeh; Reza Saghiri
Journal:  Int J Nanomedicine       Date:  2010-08-09

9.  Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin.

Authors:  Abolfazl Akbarzadeh; Nosratollah Zarghami; Haleh Mikaeili; Davoud Asgari; Amir Mohammad Goganian; Hanie Khaksar Khiabani; Mohammad Samiei; Soodabeh Davaran
Journal:  Nanotechnol Sci Appl       Date:  2012-02-07

10.  Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.

Authors:  Soodabeh Davaran; Mohammad R Rashidi; Behzad Pourabbas; Mahin Dadashzadeh; Naser Moti Haghshenas
Journal:  Int J Nanomedicine       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.